1. 3 potential blockbusters under FDA review — AbbVie gets the most out of its workers — Roche/Exelixis’ Cotellic fizzles in melanoma study — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Enanta's lung infection therapy succeeds in mid-stage trial

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 14, 2019 at 6:42 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    10,848
    Likes Received:
    3
    via Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage study.

    article source